cardiotoxicity

Chen J, Chapski DJ, Jong J, Awada J, Wang Y, Slamon DJ, Vondriska TM, Packard RRS. Integrative transcriptomics and cell systems analyses reveal protective pathways[...]

By sjmartinez • May 24, 2023

Packard RRS, Yang EH. Editorial: Novel mechanisms, imaging approaches, and management strategies for anthracycline-induced cardiotoxicity. Front Cardiovasc Med. 2023 Jan 4;9:1109078. doi: 10.3389/fcvm.2022.1109078. PMID: 36684589;[...]

By sjmartinez • January 24, 2023

Ganatra S, Dani SS, Yang EH, Zaha VG, Nohria A. Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer. JACC CardioOncol. 2022 Dec 20;4(5):616-623. doi: 10.1016/j.jaccao.2022.07.014. PMID: 36636447; PMCID:[...]

By sjmartinez • January 14, 2023

Venkatesh P, Yan KL, Bravo-Jaimes K, Yang EH, Lluri G. Outcomes of malignancy in adults with congenital heart disease: a single center experience. Cardiooncology. 2022[...]

By sjmartinez • November 25, 2022

Jong J, Pinney JR, Packard RRS. Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging. Front Cardiovasc Med. 2022 Aug 3;9:919719. doi:[...]

By sjmartinez • August 3, 2022

Stein-Merlob AF, Ganatra S, Yang EH. T-cell Immunotherapy and Cardiovascular Disease: Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies. Heart Fail Clin. 2022 Jul;18(3):443-454.[...]

By rosaguerrero • June 20, 2022

Vuong JT, Stein-Merlob AF, Cheng RK, Yang EH. Novel Therapeutics for Anthracycline Induced Cardiotoxicity. Front Cardiovasc Med. 2022 Apr 22;9:863314. doi: 10.3389/fcvm.2022.863314. PMID: 35528842; PMCID:[...]

By rosaguerrero • May 9, 2022